Project Grant K23DK146191
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded New York University School of Medicine a $158,943 Project Grant on July 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This five-year initiative, scheduled for completion by May 31, 2030, develops and tests a community health worker (CHW)-led intervention designed to support South Asian patients with Type 2 Diabetes who are at...
- Federal Project Grant Award Summary Albert Einstein College of Medicine received a $887,696 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective February 1, 2026 through November 30, 2030. The award supports proteomic research aimed at identifying blood protein signatures associated with Type 2 Diabetes (T2D) and gut dysbiosis in the Hispanic/Latino...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $188,632 to the University of Kansas Medical Center Research Institute on August 1, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for a five-year project extending through July 31, 2030. Led by Dr. Daniel Tilden, MD, MPH, an endocrinologist and rural health services researcher, this project develops and pilot tests the Rural...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Scripps Research Institute a Project Grant of $801,662 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant, awarded on August 15, 2025, with completion targeted for June 30, 2029, supports basic biomedical research investigating the early initiation phase of Type 1 Diabetes (T1D), a CD4 T cell-mediated autoimmune disease. The...
- Federal Project Grant Award Summary The Johns Hopkins University received a $819,091 Project Grant awarded September 11, 2025, from the National Institute of Diabetes and Digestive and Kidney Diseases under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award funds research through June 30, 2030, to investigate glucose patterns and clinical outcomes in the Dallas Heart Study through continuous glucose monitoring (CGM) systems and machine learning...
- Federal Grant Award Summary Albert Einstein College of Medicine received a $200,660 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 15, 2025, with a completion date of July 31, 2030. The grant supports the development and testing of a Digital Mind Body Intervention (DMBI) mobile health application specifically designed for Black and...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the Regents of the University of Michigan a $779,978 Project Grant on September 6, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This research initiative, titled "Improving Diabetes Outcomes and Health Disparities by Addressing Unmet Resource Needs," will develop and test adaptive intervention sequences to address...
- Federal Grant Award Summary The University of Michigan received a $780,220 Project Grant award dated February 27, 2026, from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports a clinical optimization trial to evaluate the effectiveness of two scalable digital behavioral intervention components for mitigating Level 2 hypoglycemia (severe low blood glucose)...
- Federal Grant Award Summary New York University received a $1.94 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 19, 2025. The grant funds a 36-month research initiative (through August 31, 2028) evaluating an adaptive dietary intervention that leverages continuous glucose monitoring (CGM) technology for Asian Americans with...
- Federal Project Grant Award Summary Baylor College of Medicine received a $324,226 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective June 20, 2025, through May 31, 2028. The award supports a pilot and feasibility evaluation of a food prescription (Food Rx) program designed to address food insecurity among youth with Type 1 Diabetes (T1D) ages...
Albert Einstein College of Medicine received a $183,558 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) effective March 1, 2026, through February 28, 2031. The award supports implementation and evaluation of T1D-PATCHY (Type 1 Diabetes-Promoting Access to Diabetes Technology with Community Health Workers for Youth), a specialty care model designed to improve diabetes technology adoption among underserved youth with Type 1 Diabetes from low-income families or on public insurance. The research addresses multi-level barriers including social needs and inadequate school support that prevent these populations from accessing diabetes devices. Under this grant, the institution will deliver three primary research products: identification of implementation barriers at school sites; development of multifaceted implementation strategies for deploying T1D-PATCHY using an implementation mapping framework; and feasibility evaluation of the intervention through a pilot randomized controlled trial conducted in Bronx, New York. The project leverages community health workers as trusted community members to bridge medical care with social support services, with exploratory outcomes measuring diabetes device uptake, resolution of social needs barriers, and implementation effectiveness. This research addresses documented health disparities in diabetes technology use and health outcomes among vulnerable youth populations.T1D-PATCHY Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $183.6k | 2/27/26 |